Screener
Aurinia Pharmaceuticals AUPH Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's other non-current liabilities?
- Aurinia Pharmaceuticals (AUPH) reported other non-current liabilities of $945K in Q2 2026.
- How has Aurinia Pharmaceuticals's other non-current liabilities changed year-over-year?
- Aurinia Pharmaceuticals's other non-current liabilities decreased by 92.1% year-over-year, from $12M to $945K.
- What is the long-term trend for Aurinia Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's other non-current liabilities has grown at a -16.4% compound annual growth rate (CAGR), from $16.3M to $6.66M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Aurinia Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude